David Hoey is the founder of Vaxxas. Vaxxas has raised $59M in total funding. Latest round: Series D. Based in Brisbane, Australia.
David Hoey is the founding CEO of Vaxxas, a biotechnology company based in Brisbane, Australia. Vaxxas is developing a high-density microarray patch (HD-MAP) for needle-free vaccine delivery, a technology that aims to improve vaccine access and uptake globally. The company recently secured approximately A$90 million in a Series D funding round, with Hoey transitioning to a Strategic Advisor role.
Full founder directory · Investor directory · Company funding database · Fundraising library